The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
methyl-1-[4-(1,6-dimethyl-5,7-dioxo-pyrimido[5,4-e][1,2,4]triazin-3-yl)phenyl]cyclopropanecarboxylate ID: ALA4639254
PubChem CID: 156013357
Max Phase: Preclinical
Molecular Formula: C18H17N5O4
Molecular Weight: 367.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)C1(c2ccc(-c3nc4c(=O)n(C)c(=O)nc-4n(C)n3)cc2)CC1
Standard InChI: InChI=1S/C18H17N5O4/c1-22-15(24)12-14(20-17(22)26)23(2)21-13(19-12)10-4-6-11(7-5-10)18(8-9-18)16(25)27-3/h4-7H,8-9H2,1-3H3
Standard InChI Key: TWFUMRWELGGOTI-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
22.0188 -10.4501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4315 -11.1600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8399 -10.4477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7483 -12.7820 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7483 -13.6033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4577 -14.0078 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4577 -12.3652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1630 -12.7820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1595 -13.6033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8657 -14.0127 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5798 -13.6093 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5833 -12.7880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8726 -12.3700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4577 -11.5439 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0371 -14.0130 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8611 -14.8340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0353 -12.3714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2955 -12.3791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0054 -12.7973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7189 -12.3890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7237 -11.5668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0090 -11.1546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2984 -11.5612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1391 -11.5706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8479 -11.1638 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.1369 -12.3877 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.5545 -11.5743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
1 3 1 0
4 5 1 0
4 7 1 0
5 6 1 0
6 9 2 0
8 7 1 0
8 9 1 0
8 13 2 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
7 14 2 0
5 15 2 0
10 16 1 0
4 17 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
12 18 1 0
21 2 1 0
2 24 1 0
24 25 1 0
24 26 2 0
25 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 367.37Molecular Weight (Monoisotopic): 367.1281AlogP: 0.25#Rotatable Bonds: 3Polar Surface Area: 108.97Molecular Species: ┄HBA: 9HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 1.20CX LogD: 1.20Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.61Np Likeness Score: -0.69
References 1. Letfus V, Jelić D, Bokulić A, Petrinić Grba A, Koštrun S.. (2020) Rational design, synthesis and biological profiling of new KDM4C inhibitors., 28 (1): [PMID:31784197 ] [10.1016/j.bmc.2019.115128 ]